Immunogenetics and the Pathological Mechanisms of Human T-Cell Leukemia Virus Type 1- (HTLV-1-)Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)
Author(s) -
Mineki Saito
Publication year - 2010
Publication title -
interdisciplinary perspectives on infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.593
H-Index - 28
eISSN - 1687-7098
pISSN - 1687-708X
DOI - 10.1155/2010/478461
Subject(s) - tropical spastic paraparesis , myelopathy , medicine , retrovirus , leukemia , immunology , disease , asymptomatic carrier , virus , virology , asymptomatic , human t lymphotropic virus , human t lymphotropic virus 1 , t cell leukemia , pathology , psychiatry , spinal cord
Human T-cell leukemia virus type 1 (HTLV-1) is a replication-competent human retrovirus associated with two distinct types of disease only in a minority of infected individuals: the malignancy known as adult T-cell leukemia (ATL) and a chronic inflammatory central nervous system disease HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Although the factors that cause these different manifestations of HTLV-1 infection are not fully understood, accumulating evidence suggests that complex virus-host interactions play an important role in determining the risk of HAM/TSP. This review focuses on the role of the immune response in controlling or limiting viral persistence in HAM/TSP patients, and the reason why some HTLV-1-infected people develop HAM/TSP whereas the majority remains asymptomatic carriers of the virus
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom